March marks Prostate Cancer Awareness Month, an important opportunity to focus on one of the most common cancers affecting men in the UK. Thousands of men are diagnosed each year, yet many cases are still identified later than they should be. The message is clear: early detection, open conversations and accessible testing can significantly improve outcomes and reduce the emotional burden on families.
At London Blood Tests, we see how simple, proactive steps — such as a PSA blood test — can help men take control of their health before symptoms become advanced. Awareness is not about fear; it is about education, action and removing stigma.
Why Early Detection Matters
Prostate cancer often develops silently. In its early stages, many men experience no symptoms at all. This is why understanding PSA testing (Prostate-Specific Antigen testing) is so important.
A PSA blood test measures the level of prostate-specific antigen in the bloodstream. Elevated levels do not automatically mean cancer, but they may indicate inflammation, enlargement or the need for further investigation. When detected early, survival rates are significantly higher. Outcomes improve dramatically when the disease is identified before it spreads.
The difficulty is that many men only seek medical advice once symptoms become noticeable — and by that point, treatment options may be more complex.
Recognising Symptoms
Although early prostate cancer may be symptom-free, more advanced stages can cause:
- Difficulty starting or stopping urination
- A weak or interrupted urine flow
- Frequent urination, particularly at night
- Blood in urine or semen
- Persistent pelvic discomfort
Any ongoing urinary change should be discussed with a GP or qualified clinician. However, waiting for symptoms is not a reliable strategy. Preventative screening remains key.
Understanding Risk Factors
Certain men face a higher risk and should consider earlier or more regular testing:
- Age – Risk increases significantly after 50
- Ethnicity – Black men are at higher risk and may develop prostate cancer earlier
- Family history – Having a father or brother with prostate cancer increases risk
- Genetic predisposition – Certain inherited gene mutations may contribute
Men in higher-risk groups are often advised to begin conversations about PSA testing earlier, even if they feel completely well.
Advances in Treatment
Prostate cancer care has evolved significantly in recent years. Treatment options now include active surveillance for low-risk cases, surgery, radiotherapy, hormone therapy, targeted therapies and, in selected cases, immunotherapy. Ongoing research continues to refine personalised approaches, improving outcomes while reducing side effects. More men today are living longer and maintaining quality of life after diagnosis.
The Emotional and Social Impact
A prostate cancer diagnosis affects more than physical health. It can influence confidence, identity, sexual health, relationships and mental wellbeing. Many men still find it difficult to discuss these concerns openly, which can delay support and recovery.
Breaking this silence is essential. Honest conversations with clinicians, partners, family members and employers can significantly improve coping and resilience. Emotional support should be considered part of comprehensive care.
Employers also have a role to play by promoting men’s health awareness, allowing flexibility for appointments and fostering a culture where health discussions are normal and confidential.
Taking Action This March
Men over 50 — or over 45 if in a higher-risk group — should consider discussing PSA testing with a healthcare professional.
For those seeking convenient access to screening, London Blood Tests offers PSA testing as part of its men’s health and prostate health assessments, with results reviewed in clinical context to ensure appropriate follow-up where needed.
To support Prostate Cancer Awareness Month, we are offering 20% off all tests and assessments throughout March using code LBT001. Our home finger-prick testing kits are also available for £30 per kit plus PSA analysis during this period.
The goal is not over-testing, but informed decision-making.
Prostate cancer remains one of the most common cancers in men, yet conversations about men’s health are often limited. Encouraging fathers, brothers, partners and colleagues to talk openly about screening can remove stigma and save lives.
This March, let’s move from silence to action. Early detection changes outcomes. Education changes behaviour. Conversations change culture — and together, those changes save lives.
